Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study

Podobne zapisy

• Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial
  od: Malbrán, A, i wsp.
  Wydane: (2014)
• The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
  od: Longhurst, Hilary J., i wsp.
  Wydane: (2016)
• Management of acute attacks of hereditary angioedema: potential role of icatibant
  od: Longhurst, Hilary J
  Wydane: (2010)
• Therapeutic trial in hereditary angioedema type III: Icatibant
  od: Garro, Laila Sabino, i wsp.
  Wydane: (2015)
• Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
  od: Riedl, Marc A., i wsp.
  Wydane: (2020)